Biomaterial Database

C3 polymorphism, HLA and chronic renal failure in Spaniards. 1984

J R Regueiro, and A Arnaiz-Villena

C3 allele frequencies were studied in 196 unrelated normal Spaniards. The results fit the Hardy-Weinberg equilibrium. No rare variants were detected. The C3 frequency was close but slightly higher than that found in other Caucasoid populations, and higher than that found in Negroids and Orientals. Spanish Basques also showed a high C3F frequency. A North-South decreasing C3F gradient was recorded and compared to other gradients (HLA-D/DR, height, etc.) thought to be due to natural selection. Lod scores in 28 Spanish families excluded C3 gene assignment at less than 45 cM of HLA/GLO linkage group; no significant linkage disequilibrium was found between C3 and HLA. C3F was also significantly increased in 20 chronic renal failure (CRF) patients as compared to 196 controls; this would support the existence of functional differences between C3F and C3S alleles.

UI	MeSH Term	Description	Entries
D007676	Kidney Failure, Chronic	The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.	ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008126	Lod Score	The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds."	Lod Scores,Score, Lod,Scores, Lod
D008297	Male		Males
D011110	Polymorphism, Genetic	The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level.	Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D003176	Complement C3	A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase.	C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D005006	Ethnicity	A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships.	Ethnic Groups,Nationality,Ethnic Group,Nationalities
D005260	Female		Females
D005787	Gene Frequency	The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION.	Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006680	HLA Antigens	Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.	Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J R Regueiro, and A Arnaiz-Villena

Polymorphism of C3 components and the B factor in patients with chronic renal failure, dialyzed iteratively.

January 1985, Medecine interne,

J R Regueiro, and A Arnaiz-Villena

C3 and Bf complement types in chronic renal failure.

March 1986, Human genetics,

J R Regueiro, and A Arnaiz-Villena

C3 polymorphism in patients with chronic uremia.

January 1980, Human heredity,

J R Regueiro, and A Arnaiz-Villena

HLA polymorphism in Sudanese renal donors.

July 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,

J R Regueiro, and A Arnaiz-Villena

Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.

March 2007, Journal of the American Society of Nephrology : JASN,

J R Regueiro, and A Arnaiz-Villena

Two new HLA-B35 subtypes characterized in Spaniards: HLA-B*35:270 and HLA-B*35:273.

November 2015, Tissue antigens,

J R Regueiro, and A Arnaiz-Villena

CCR2 polymorphism in chronic renal failure patients requiring long-term hemodialysis.

January 2011, Internal medicine (Tokyo, Japan),

J R Regueiro, and A Arnaiz-Villena

Complement C3 gene polymorphism in renal transplantation (an Iranian experience).

May 2012, Gene,